IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421,500 | -35.2% | 92,537 | +0.1% | 0.00% | – |
| Q2 2023 | $650,384 | +102.4% | 92,449 | +75.7% | 0.00% | – |
| Q1 2023 | $321,299 | +109.3% | 52,628 | +118.9% | 0.00% | – |
| Q4 2022 | $153,526 | -33.6% | 24,044 | -50.0% | 0.00% | – |
| Q3 2022 | $231,231 | -12.7% | 48,090 | +99.8% | 0.00% | – |
| Q2 2022 | $265,000 | -33.6% | 24,069 | +0.3% | 0.00% | – |
| Q1 2022 | $399,000 | -12.9% | 24,001 | +0.1% | 0.00% | – |
| Q4 2021 | $458,000 | -81.5% | 23,985 | -69.3% | 0.00% | -100.0% |
| Q1 2021 | $2,476,000 | +196.9% | 78,211 | +334.4% | 0.00% | – |
| Q4 2020 | $834,000 | – | 18,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |